[Erythroleukemia and sarcolysine].
D005260:Female; D006801:Humans; D004915:Leukemia, Erythroblastic, Acute / Q000139:chemically induced*; D008558:Melphalan / Q000009:adverse effects* / Q000627:therapeutic use; D008875:Middle Aged; D009230:Myxedema / Q000188:drug therapy; D012871:Skin Diseases / Q000188:drug therapy
D008558:Melphalan
Erythroleukemie en sarcolysine.